Wells Fargo & Company Abb Vie Inc. Call Options Transaction History

Wells Fargo & Company

12 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2024 May 10, 2024	SELL	$159.82 - $182.1 $44.4 Million - $50.6 Million	-277,900 Reduced 98.02%	5,600 $1.02 Million
Q4 2023 Feb 09, 2024	BUY	$137.6 - $154.97 $23.9 Million - $26.9 Million	173,800 Added 158.43%	283,500 $43.9 Million
Q3 2023 Nov 13, 2023	BUY	$133.59 - $154.65 $14.5 Million - $16.7 Million	108,200 Added 7213.33%	109,700 $16.4 Million
Q2 2023 Aug 15, 2023	SELL	$132.51 - $164.9 $874,565 - $1.09 Million	-6,600 Reduced 81.48%	1,500 $202,000
Q1 2023 May 12, 2023	BUY	$144.61 - $166.54 $954,426 - $1.1 Million	6,600 Added 440.0%	8,100 $1.29 Million
Q4 2022 Feb 13, 2023	SELL	$138.31 - $165.87 $3.47 Million - $4.16 Million	-25,100 Reduced 94.36%	1,500 $242,000
Q3 2022 Nov 14, 2022	BUY	$134.21 - $153.93 $214,736 - $246,288	1,600 Added 6.4%	26,600 $3.57 Million
Q2 2022 Aug 12, 2022	SELL	$137.62 - $174.96 $3.44 Million - $4.37 Million	-25,000 Reduced 50.0%	25,000 $3.83 Million
Q4 2021 Feb 14, 2022	BUY	$107.43 - $135.93 $1.14 Million - $1.44 Million	10,600 Added 26.9%	50,000 $6.77 Million
Q1 2021 May 13, 2021	BUY	$102.3 - $112.62 $1.09 Million - $1.21 Million	10,700 Added 37.28%	39,400 $4.26 Million
Q3 2020 Nov 05, 2020	SELL	$85.91 - $100.83 $4.42 Million - $5.19 Million	-51,500 Reduced 64.21%	28,700 $45,000
Q1 2020 May 14, 2020	BUY	$64.5 - $97.79 $5.17 Million - $7.84 Million	80,200 New	80,200 $19,000

3,853

1.25B

16.8M

12.2M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

Stay updated on Wells Fargo & Company with notifications on news.